Page last updated: 2024-10-28

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Acquired-Immune Deficiency Syndrome Dementia Complex

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Acquired-Immune Deficiency Syndrome Dementia Complex in 1 studies

1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chong, YH1
Lee, MJ1

Other Studies

1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Acquired-Immune Deficiency Syndrome Dementia Complex

ArticleYear
Effect of HIV-1 gp41 peptides on secretion of beta-amyloid precursor protein in human astroglial cell line, T98G.
    Journal of molecular neuroscience : MN, 1999, Volume: 12, Issue:2

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; AIDS Dementia Complex; Amyloid beta-Protein Precursor

1999